
“Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs. Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.”
Related posts:
Brazil confirms investigation into reports of NSA spying
Scientists used modified T-cells to wipe out childhood leukemia in a little girl
Edward Snowden: 'The people are still powerless, but now they're aware'
Houston schools discuss child's 'Nerf gun' suspension
Men Find Careers in Collecting Disability
Black Panther's conviction overturned after 43 years in Louisiana solitary cell
Ron Paul: "I Smell Iraq All Over Again"
Snowden files reveal NSA spied on Brazil and Mexico presidents
South Korean toddler gets first ever windpipe transplant
IRS Moves To Revoke Passports For Unpaid Taxes
Obama extends US military mission in Afghanistan into 2017
Supreme Court to consider if silence can be evidence of guilt
Treasury chief Jacob Lew not worried about financial bubble
London Seeks New Spenders as Russians Skip $719 Champagne
McCain: $1 coin could lead to bigger tips for strippers